NCT05332210 2026-04-28Evaluate the Safety of HBM9161 (HL161) Subcutaneous Injection in Patients With Generalized Myasthenia GravisHarbour BioMed (Guangzhou) Co. Ltd.Phase 3 Completed111 enrolled